Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-010229
Filing Date
2020-04-03
Accepted
2020-04-03 18:04:47
Documents
2
Period of Report
2020-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4330
2 EX-24 DOCUMENT attachment1.htm EX-24 3483
  Complete submission text file 0000899243-20-010229.txt   9278
Mailing Address C/O AISLING CAPITAL 888 SEVENTH AVENUE, 30TH FLOOR NEW YORK NY 10106
Business Address
SUN ANTHONY Y (Reporting) CIK: 0001377952 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39263 | Film No.: 20775154

Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, LLC (Issuer) CIK: 0001725160 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations